ACH Accendra Health, Inc. Common Stock
NYSE · Health Care · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Jan 24, 2024ACH Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
ACH Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
| Tanggal ex-dividen | Pemecahan | Tipe |
|---|---|---|
| 1 April 2010 | 3-for-2 | Maju |
| 9 Juni 1994 | 3-for-2 | Maju |
| 23 Maret 1993 | 3-for-2 | Maju |
| 17 Juli 1991 | 3-for-2 | Maju |
| 1 Juni 1988 | 3-for-2 | Maju |
| 3 Sep. 1985 | 3-for-2 | Maju |
| 1 Nov. 1982 | 2-for-1 | Maju |
Tentang Accendra Health, Inc. Common Stock Tinjauan perusahaan dari Wikipedia
Accendra Health is a global healthcare company. It employs over 20,000 people in 70 countries. A Fortune 500 company, it was founded in 1882 in Richmond, Virginia, where it remains headquartered. The company has distribution, production, customer service and sales facilities located across the Asia Pacific region, Europe, Latin America, and North America. President and CEO Ed Pesicka joined Owens & Minor in March 2019.
History
Owens & Minor originally opened as a pharmacy company in downtown Richmond, Virginia in 1882, inside a historic building which still stands today. The company continued this business for over half a century until, in 1954, Gil Minor, Jr. bought out Bodeker Drug Company, a smaller operation in the same industry, changing the company name to Owens, Minor & Bodeker.
In 1966, the company acquired Virginia A&J Hospital Supply, adding medical and surgical distribution to its portfolio. By 1970, OMB had opened Cardinal Drug Centers, merchandising its products to independent drug companies, stocking shops with over 25,000 items within two years. Around this time, disposable items were distributed to hospitals for various medical procedures. G. Gilmer Minor III, a direct relation to the founder, became CEO in 1984. By 1988, Owens & Minor began trading on the New York Stock Exchange under the ticker OMI. It was around this time that revenues earned the company a Fortune 500 ranking.
By 1999, the company had refocused toward medical supply chain management. Throughout the 2000s, Owens & Minor acquired various medical distributors across the United States, notably the hospital distributor McKesson Medical-Surgical Inc., a business unit of McKesson, for $152.1 million, on September 30, 2006. In 2012, it entered the European market, opening offices in Spain, France, Germany, Poland, and the Czech Republic after the acquisition of Movianto Group. In 2014, the corporation acquired ArcRoyal, a privately held medical kit company based in Dublin, Ireland.
In 2018, it acquired Halyard Health’s Surgical & Infection Prevention business for $710 million, the largest acquisition in the company’s history. Halyard is a manufacturer of sterilization wrap, facial protection products, exam gloves, protective apparel, surgical drapes and surgical gowns.
In May 2022, Owens & Minor stated that 45 percent of the items it offers are in some way supply-constrained due to the 2021–2022 global supply chain crisis. The following month, the company broke ground in Morgantown, West Virginia for a 350,000 square-foot medical supplies and logistics center, to be completed in late 2023, which will include dedicated acute care medical distribution facilities and clinical supply capabilities.
In July 2024, the company announced it had agreed to acquire medical equipment firm Rotech Healthcare for $1.36 billion. However, the companies terminated the deal in June 2025, citing regulatory hurtles. As a result, the Owens & Minor paid Rotech an $80 million termination payment.
Personnel
On March 7, 2019 Edward A. Pesicka became president and CEO, then also joined the company's Board of Directors. Pesicka was a former executive at Thermo Fisher Scientific.
Richmond, Virginia center
In the fourth quarter of 2017, Owens & Minor opened a second office and customer service center in downtown Richmond, Virginia as part of a business rebranding strategy. The corporation also continued to work from its various offices across the United States.
Movianto
In 2018, the company’s Movianto subsidiary won a contract estimated at £10.5m a year to warehouse and distribute the UK government’s stock of emergency personal protection equipment (PPE) which had previously been managed by DHL.
Following a dispute over payment of rent, Movianto gained a UK High Court injunction in March 2019 to stop Industrial North West LLP, owner of the rented industrial property, from locking the gates and thereby preventing the company from conducting its business.
In 2020, Movianto was criticised as causing delays to the distribution of the UK government’s stockpile of PPE. Following news of shortages in hospitals, the British army was sent to Movianto’s warehouse to assist in the rapid deployment of PPE, with the Department of Health and Social Care contradicting the allegation. An investigation did establish, however, that Movianto had previously stored the equipment in a smoke-damaged warehouse that was found to contain asbestos.
On January 16, 2020, Owens & Minor announced its intention to sell its European logistics business, Movianto, to EHDH Holding Group (EHDH), a privately held French company providing healthcare logistics services to European markets, with the sale completed June 18, 2020.
Divest of P&HS - Rebrand Accendra Health, Inc.
On December 31 2025, Owens & Minor, Inc. announced the completion of the sale of its Products & Healthcare Services (P&HS) segment and the Owens & Minor brand to Platinum Equity and is renaming the publicly traded parent company Accendra Health, Inc.
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Data fundamental belum cukup untuk menghitung grup rasio ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Data fundamental belum cukup untuk menghitung grup rasio ini.
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Data fundamental belum cukup untuk menghitung grup rasio ini.
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Data fundamental belum cukup untuk menghitung grup rasio ini.
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Dividen Yield, rasio pembayaran, riwayat dividen, CAGR 5 tahun
| Tanggal ex-dividen | Jumlah | Mata Uang | Imbal Hasil |
|---|---|---|---|
| Des 14, 2021 | $0,00 | USD | ≈0.03% |
| Sep 14, 2021 | $0,00 | USD | ≈0.03% |
| Jun 14, 2021 | $0,00 | USD | ≈0.03% |
| Mar 12, 2021 | $0,00 | USD | ≈0.03% |
| Des 14, 2020 | $0,00 | USD | ≈0.04% |
| Sep 14, 2020 | $0,00 | USD | ≈0.08% |
| Jun 12, 2020 | $0,00 | USD | ≈0.16% |
| Mar 13, 2020 | $0,00 | USD | ≈0.28% |
| Des 13, 2019 | $0,00 | USD | ≈1.6% |
| Sep 13, 2019 | $0,00 | USD | ≈5.5% |
| Jun 13, 2019 | $0,00 | USD | ≈20.8% |
| Mar 14, 2019 | $0,00 | USD | ≈12.6% |
| Des 14, 2018 | $0,08 | USD | ≈13.2% |
| Sep 14, 2018 | $0,26 | USD | ≈6.4% |
| Jun 14, 2018 | $0,26 | USD | ≈6.4% |
| Mar 14, 2018 | $0,26 | USD | ≈6.2% |
| Des 14, 2017 | $0,26 | USD | ≈5.5% |
| Sep 14, 2017 | $0,26 | USD | ≈3.6% |
| Jun 13, 2017 | $0,26 | USD | ≈3.2% |
| Mar 13, 2017 | $0,26 | USD | ≈2.9% |
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 10, 2026 | $-0.19 | $-0.09 | -113.0% |
| 31 Maret 2026 | $-0.04 | $-0.10 | 60.9% | |
| 31 Des. 2025 | $0.21 | $0.22 | -5.8% | |
| 30 Sep. 2025 | $0.25 | $0.23 | 6.7% | |
| 30 Juni 2025 | $0.26 | $0.28 | -6.3% | |
| 31 Maret 2025 | $0.23 | $0.20 | 16.6% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $290.99B | $298.89B | $203.99B | $190.22B | $180.35B | $181.02B | $144.85B | |
| Cost of Revenue | $259.70B | $264.17B | $188.52B | $179.28B | $167.11B | $166.29B | $133.70B | |
| Gross Profit | $31.28B | $34.72B | $15.47B | $10.93B | $13.24B | $14.73B | $11.15B | |
| R&D Expense | $4.81B | $2.42B | $1.47B | $941M | $627M | $498M | $169M | |
| SG&A Expense | $6.01B | $6.33B | $5.06B | $3.97B | $3.98B | $4.55B | · | |
| Operating Income | $16.39B | $18.67B | $7.60B | $6.21B | $6.82B | · | · | |
| Interest Expense | $3.83B | $4.51B | $4.99B | $4.38B | $4.69B | $4.83B | $4.76B | |
| Interest Income | $477M | $311M | $266M | $261M | $492M | $707M | $816M | |
| Pretax Income | $13.21B | $14.19B | $2.89B | $1.87B | $2.27B | $3.05B | $1.62B | |
| Income Tax | $2.37B | $2.87B | $641M | $632M | $826M | $644M | $404M | |
| Net Income | $4.19B | $5.76B | $862M | $596M | $709M | $1.41B | $366M | |
| EPS (Basic) | $0.24 | $0.33 | $0.03 | $0.02 | $0.03 | $0.09 | $0.02 | |
| EPS (Diluted) | $0.24 | $0.33 | $0.03 | $0.02 | · | · | · | |
| Shares (Basic) | 17,022,673 | 17,022,673 | 17,022,673 | 17,022,673 | 16,842,714 | 14,903,798,236 | 14,903,798,236 | |
| Shares (Diluted) | · | · | · | 17,022,672,951 | 16,842,713,738 | 14,903,798,236 | 14,903,798,236 | |
| EBITDA | $16.39B | $13.41B | $6.02B | · | · | · | · |
Neraca
| Metrik | Tren | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16.82B | $19.68B | $9.67B | $7.78B | $19.13B | $27.85B | $23.85B | |
| Receivables | $5.87B | $7.11B | $9.31B | $7.42B | $8.10B | · | · | |
| Inventory | $24.71B | $21.64B | $19.86B | $19.52B | $20.46B | $20.55B | $17.93B | |
| Current Assets | $54.54B | $54.11B | $46.27B | $48.70B | $58.90B | $68.64B | $66.49B | |
| PP&E (Net) | $109.28B | $121.38B | $130.93B | $103.49B | $99.61B | $95.73B | $90.37B | |
| Goodwill | $3.50B | $3.51B | $3.51B | · | · | · | · | |
| Total Assets | $212.35B | $224.86B | $195.04B | $203.14B | $200.96B | $199.82B | $190.51B | |
| Current Liabilities | $62.37B | $61.92B | $62.63B | $69.20B | $74.84B | $90.34B | $83.18B | |
| Total Liabilities | $124.59B | $135.17B | $123.74B | $132.38B | $133.30B | $134.07B | $134.72B | |
| Retained Earnings | $10.09B | $6.81B | $-1.98B | $-2.21B | $-2.86B | $-3.33B | $-4.64B | |
| Stockholders' Equity | $54.40B | $60.48B | $54.45B | $54.67B | $52.42B | $39.69B | $38.17B |
Arus Kas
| Metrik | Tren | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | $8.06B | $7.06B | $7.00B | |
| Operating Cash Flow | $27.75B | $35.16B | $19.42B | $12.51B | $13.02B | $13.21B | $11.61B | |
| CapEx | $4.42B | $3.19B | $10.33B | $9.05B | $6.75B | $8.89B | $6.33B | |
| Investing Cash Flow | $-3.42B | $-1.67B | $-3.31B | $-13.40B | $-5.53B | $-5.60B | $-2.63B | |
| Dividends Paid | $2.51B | $579M | $423M | $223M | $328M | $309M | $20M | |
| Financing Cash Flow | $-27.04B | $-23.41B | $-18.23B | $-10.47B | $-16.28B | $-3.39B | $-6.11B | |
| Free Cash Flow | $23.33B | $26.19B | $9.84B | $3.58B | · | · | · | |
| Levered FCF | $20.19B | $23.50B | $7.02B | $501M | · | · | · |
Profitabilitas
| Metrik | Tren | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 10.8% | 9.8% | 7.2% | 6.4% | · | · | · | |
| Operating Margin | 5.6% | 5.0% | 3.2% | · | · | · | · | |
| Net Margin | 1.4% | 1.9% | 0.40% | 0.45% | · | · | · | |
| Pretax Margin | 4.5% | 3.8% | 1.2% | 1.1% | · | · | · | |
| EBITDA Margin | 5.6% | 5.0% | 3.2% | · | · | · | · | |
| ROA | 1.9% | 2.6% | 0.37% | 0.42% | · | · | · | |
| ROE | 7.3% | 9.1% | 1.4% | 1.6% | · | · | · | |
| ROIC | 24.7% | 17.9% | 8.1% | · | · | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 0.7 | 0.7 | · | · | · | |
| Quick Ratio | 0.4 | 0.5 | 0.3 | 0.2 | · | · | · | |
| Interest Coverage | 4.3 | 3.8 | 1.6 | · | · | · | · |
Efisiensi
| Metrik | Tren | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.3 | 1.4 | 0.9 | 0.9 | · | · | · | |
| Inventory Turnover | 11.2 | 12.6 | 8.8 | 8.9 | · | · | · | |
| Receivables Turnover | 44.8 | 33.3 | 22.3 | 24.5 | · | · | · |
Per Saham
| Metrik | Tren | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue / Share | · | · | · | $11.17 | · | · | · | |
| Cash Flow / Share | · | · | · | $0.73 | · | · | · | |
| EPS (TTM) | $0.24 | $0.29 | $0.03 | $0.02 | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $290.99B | $269.75B | $185.99B | $190.22B | · | · | · | |
| Net Income TTM | $4.19B | $5.08B | $764M | $596M | · | · | · | |
| P/E | 81.7 | 152.1 | 901.7 | 235.0 | · | · | · | |
| Earnings Yield | 1.2% | 0.66% | 0.11% | 0.43% | · | · | · | |
| Payout Ratio | 60.0% | 9.1% | 48.1% | 26.2% | · | · | · | |
| Annual Payout | $2.51B | $461M | $356M | $223M | · | · | · |
Per Saham
| Metrik | Tren | Q4 2022 | Q4 2021 | Q4 2019 | Q4 2018 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS (TTM) | · | $0.29 | · | · | · | · | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | Q4 2022 | Q4 2021 | Q4 2019 | Q4 2018 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $269.75B | · | · | $144.85B | $123.67B | · | · | · | · | · | |
| Net Income TTM | · | $5.08B | · | · | $366M | $130M | · | · | · | · | · | |
| P/E | · | 152.1 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | · | 0.66% | · | · | · | · | · | · | · | · | · | |
| Annual Payout | · | $461M | · | · | $20M | $20M | · | · | · | · | · |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $290.99B | $298.89B | $203.99B | $190.22B | $180.35B |
| Margin Kotor % | 10.8% | 9.8% | 7.2% | 6.4% | · |
| Margin Operasi % | 5.6% | 5.0% | 3.2% | · | · |
| Laba Bersih | $4.19B | $5.76B | $862M | $596M | $709M |
| EPS Dilusian | $0.24 | $0.33 | $0.03 | $0.02 | · |
| Metrik | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 0.9 | 0.9 | 0.7 | 0.7 | · |
| Rasio Cepat | 0.4 | 0.5 | 0.3 | 0.2 | · |
| Metrik | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $23.33B | $26.19B | $9.84B | $3.58B | · |
Pemilik institusional (13F) 161 pengaju · $236.6M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 22 (-7 vs Kuartal sebelumnya) | 21 (-25 vs Kuartal sebelumnya) | 47 (+8 vs Kuartal sebelumnya) | 45 (-7 vs Kuartal sebelumnya) | -61K |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Coliseum Capital Management, LLC | $44.804.760 | 13.100.807 | 18,94% | Saham |
| BlackRock, Inc. | $18.824.028 | 5.504.102 | 7,96% | Saham |
| VANGUARD GROUP INC | $17.691.199 | 6.318.285 | 7,48% | Saham |
| BANK OF AMERICA CORP /DE/ | $12.912.296 | 3.775.525 | 5,46% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $10.560.724 | 3.087.931 | 4,46% | Saham |
| D. E. Shaw & Co., Inc. | $10.538.412 | 3.081.407 | 4,45% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9.877.158 | 2.888.058 | 4,17% | Saham |
| Invenomic Capital Management LP | $9.618.661 | 2.812.474 | 4,07% | Saham |
| MARSHALL WACE, LLP | $8.832.423 | 2.582.579 | 3,73% | Saham |
| PARADIGM CAPITAL MANAGEMENT INC/NY | $8.675.511 | 2.536.699 | 3,67% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6.945.870 | 2.030.956 | 2,94% | Saham |
| Dana Investment Advisors, Inc. | $6.650.556 | 1.944.607 | 2,81% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $6.408.062 | 1.873.127 | 2,71% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $5.609.358 | 1.640.163 | 2,37% | Saham |
| STATE STREET CORP | $5.475.974 | 1.601.162 | 2,31% | Saham |
| Connor, Clark & Lunn Investment Management Ltd. | $4.407.652 | 1.288.787 | 1,86% | Saham |
| AQR CAPITAL MANAGEMENT LLC | $3.650.249 | 1.067.324 | 1,54% | Saham |
| GOLDMAN SACHS GROUP INC | $2.923.176 | 854.730 | 1,24% | Saham |
| TWO SIGMA INVESTMENTS, LP | $2.457.441 | 718.550 | 1,04% | Saham |
| NORTHERN TRUST CORP | $1.989.770 | 581.804 | 0,84% | Saham |
| WOLVERINE ASSET MANAGEMENT LLC | $1.942.847 | 568.084 | 0,82% | Saham |
| TUDOR INVESTMENT CORP ET AL | $1.939.995 | 567.250 | 0,82% | Saham |
| JANE STREET GROUP, LLC | $1.833.462 | 536.100 | 0,77% | Opsi beli |
| Vanguard Global Advisers, LLC | $1.742.463 | 509.492 | 0,74% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $1.665.913 | 487.109 | 0,70% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.575.252 | 460.600 | 0,67% | Opsi beli |
| TWO SIGMA ADVISERS, LP | $1.518.922 | 542.472 | 0,64% | Saham |
| BW Gestao de Investimentos Ltda. | $1.446.971 | 423.091 | 0,61% | Saham |
| CITADEL ADVISORS LLC | $1.321.919 | 386.526 | 0,56% | Saham |
| CITADEL ADVISORS LLC | $1.191.528 | 348.400 | 0,50% | Opsi beli |
| Nebula Research & Development LLC | $1.115.105 | 122.539 | 0,47% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $1.109.492 | 324.413 | 0,47% | Saham |
| MORGAN STANLEY | $1.052.342 | 307.701 | 0,44% | Saham |
| Linden Thomas Advisory Services, LLC | $932.501 | 272.661 | 0,39% | Saham |
| Bank of New York Mellon Corp | $917.257 | 268.204 | 0,39% | Saham |
| Nuveen, LLC | $803.515 | 234.946 | 0,34% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $794.692 | 232.366 | 0,34% | Saham |
| Kennondale Capital Management LLC | $772.544 | 225.890 | 0,33% | Saham |
| STRS OHIO | $716.148 | 209.400 | 0,30% | Saham |
| MILLENNIUM MANAGEMENT LLC | $690.902 | 202.018 | 0,29% | Saham |
| Cubist Systematic Strategies, LLC | $593.424 | 123.630 | 0,25% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $546.095 | 159.677 | 0,23% | Saham |
| WELLS FARGO & COMPANY/MN | $542.754 | 158.700 | 0,23% | Saham |
| XTX Topco Ltd | $503.725 | 147.288 | 0,21% | Saham |
| ARISTEIA CAPITAL, L.L.C. | $447.391 | 130.816 | 0,19% | Saham |
| Invesco Ltd. | $446.351 | 130.512 | 0,19% | Saham |
| Man Group plc | $436.009 | 127.488 | 0,18% | Saham |
| RAYMOND JAMES FINANCIAL INC | $408.047 | 119.312 | 0,17% | Saham |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $362.520 | 106.000 | 0,15% | Saham |
| Allspring Global Investments Holdings, LLC | $356.879 | 99.687 | 0,15% | Saham |
Kepemilikan ETF Dimiliki oleh 18 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| VFVA · VANGUARD WELLINGTON FUND | 0,17% | 426.785 SH | 19 Agu 2026 | Harian |
| QIDX · Spinnaker ETF Series | 0,11% | 14.310 NS | 31 Juli 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 62.833 SH | 19 Agu 2026 | Harian |
| IWC · iShares Trust | 0,02% | 248.081 SH | 11 Sep. 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 414.904 SH | 19 Agu 2026 | Harian |
| DFSV · Dimensional ETF Trust | 0,01% | 233.042 NS | 31 Juli 2026 | N-PORT |
| RSSL · Global X Funds | 0,01% | 34.414 NS | 31 Juli 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,00% | 134.690 NS | 31 Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 1.902.936 SH | 11 Sep. 2026 | Harian |
| PRF · Invesco Exchange-Traded Fund Trust | 0,00% | 96.796 SH | 1 Okt. 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,00% | 29.296 NS | 31 Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 105.616 SH | 8 Sep. 2026 | Harian |
| IWV · iShares Trust | 0,00% | 19.827 SH | 3 Sep. 2026 | Harian |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 833.270 SH | 19 Agu 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.185.973 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.453 SH | 19 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,00% | 184.892 SH | 19 Agu 2026 | Harian |
| IWN · iShares Trust | · | 666.394 SH | 11 Sep. 2026 | Harian |
ACH Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
Target Harga 12 Bulan
4 analis · 2026-09-30Target rata-rata $1.51 +199,4%
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.